Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB00530"

No prefix for http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/.

Predicate	Value (sorted: none)
owl:sameAs	?:DBSALT000064
owl:sameAs	?:Nefazodone
ns1:interactsWith	?:Erythromycin
owl:sameAs	?:Trastuzumab
owl:sameAs	?:Rifampicin
ns1:interactsWith	?:Saquinavir
ns1:interactsWith	?:St. John's Wort
owl:sameAs	?:Indinavir
ns1:interactsWith	?:Indinavir
ns1:interactsWith	?:Ketoconazole
ns1:interactsWith	?:Rifapentine
owl:sameAs	?:Atazanavir
rdfs:label	"Erlotinib"
rdf:type	ns1:drugs
owl:sameAs	?:APRD00951
owl:sameAs	?:Erythromycin
owl:sameAs	?:Saquinavir
owl:sameAs	?:Erlotinib
owl:sameAs	?:Telithromycin
ns1:interactsWith	?:Rifampicin
ns1:interactsWith	?:Atazanavir
ns1:interactsWith	?:Trastuzumab
owl:sameAs	?:Ritonavir
owl:sameAs	?:Ketoconazole
ns1:interactsWith	?:Clarithromycin
owl:sameAs	?:Itraconazole
ns1:interactsWith	?:Rifabutin
ns1:interactsWith	?:Itraconazole
owl:sameAs	?:Clarithromycin
owl:sameAs	?:Rifabutin
ns1:interactsWith	?:Ritonavir
ns1:drugCategory	?:Protein Kinase Inhibitors
owl:sameAs	?:Nelfinavir
ns1:interactsWith	?:Nelfinavir
owl:sameAs	?:Voriconazole
owl:sameAs	?:St. John's Wort
ns1:interactsWith	?:Nefazodone
owl:sameAs	?:Rifapentine
ns1:interactsWith	?:Telithromycin
ns1:interactsWith	?:Troleandomycin
ns1:interactsWith	?:Voriconazole
ns1:description	"Erlotinib hydrochloride (trade name Tarceva, Genentech/OSIP, originally coded as OSI-774) is a drug used to treat non-small cell lung cancer, pancreatic cancer and several other types of cancer. Similar to gefitinib, erlotinib specifically targets the epidermal growth factor receptor (EGFR) tyrosine kinase. It binds in a reversible fashion to the adenosine triphosphate (ATP) binding site of the receptor. Erlotinib has recently been shown to be a potent inhibitor of JAK2V617F activity. JAK2V617F is a mutant of tyrosine kinase JAK2, is found in most patients with polycythemia vera (PV) and a substantial proportion of patients with idiopathic myelofibrosis or essential thrombocythemia. The study suggests that erlotinib may be used for treatment of JAK2V617F-positive PV and other myeloproliferative disorders."
owl:sameAs	?:Troleandomycin

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/drugbank_small.nt

The resource appears as object in 37 triples

Context graph